Cortisol And Mental Health Overview Research

Last updated: October 4, 2026 - Reviewed by Verdant Wellness Editorial Team

RD

By Gabriela Mitchell, Registered Dietitian (Linkedin)

Last Updated September 2026  ·  36 min read

10% off · weekly tips

Real science on cortisol, stress, and sleep.

Send it →

---

Table of Contents

1. What Is Cortisol and Why Does It Matter for Mental Health?
2. The HPA Axis: The Brain's Stress Control Center
3. Cortisol and Anxiety: What the Research Actually Shows
4. Cortisol and Depression: A More Complex Picture
5. Cortisol and Mood Disorders Beyond Depression
6. Diurnal Cortisol Patterns: Morning vs. Evening Cortisol
7. Cortisol, Suicidal Behaviors, and Self-Injury
8. Childhood Adversity, Blunted Cortisol, and Long-Term Mental Health Risk
9. Cortisol, Sleep, and Cognitive Function
10. Measuring Cortisol: Saliva, Blood, Hair, and Urine Testing
11. Can Cortisol Testing Diagnose Mental Illness?
12. Chronic High Cortisol: Symptoms and Mental Health Consequences
13. HPA Psychiatric Disorders: What the Clinical Evidence Shows
14. How Stress Changes Cortisol Over Time: Bidirectional Relationships
15. Frequently Asked Questions
16. Key Takeaways and Summary

---

What Is Cortisol and Why Does It Matter for Mental Health?

Cortisol is a glucocorticoid steroid hormone produced and released by the adrenal cortex, the outer layer of the adrenal glands that sit atop each kidney. It is often called the body's primary "stress hormone," but that label is both accurate and incomplete. Cortisol does far more than respond to stress. It regulates blood sugar, modulates immune function, controls blood pressure, influences metabolism, governs the sleep-wake cycle, and — critically for our purposes — shapes how the brain processes emotion, memory, and threat.

When researchers talk about cortisol mental health research, they are really talking about a two-way street. Mental states affect cortisol levels, and cortisol levels in turn affect mental states. This bidirectional relationship is what makes cortisol one of the most actively studied biomarkers in psychiatry and clinical psychology today.

Cortisol exerts its effects on the brain primarily through two receptor types: glucocorticoid receptors (GRs) and mineralocorticoid receptors (MRs). These receptors are found in high concentrations in the hippocampus, amygdala, and prefrontal cortex — precisely the brain regions most involved in emotional regulation, fear learning, and executive function. When cortisol binds to these receptors, it changes gene expression, alters synaptic plasticity, and modifies how neurons communicate with one another.

Acute cortisol release — a short burst in response to a genuine threat — is adaptive. It sharpens attention, mobilizes energy, and prepares the body to respond. The problem arises when cortisol secretion becomes dysregulated: chronically too high, chronically too low, or following an abnormal daily rhythm. It is this dysregulation, rather than any single cortisol reading, that connects most strongly to cortisol mental illness outcomes in the research literature.

Understanding this fundamental biology is the starting point for any serious cortisol and mental health overview — and it explains why researchers continue to invest enormous resources in studying how the stress hormone system operates in people with psychiatric conditions.

---

The HPA Axis: The Brain's Stress Control Center

To understand cortisol's relationship with mental health, you must first understand the hypothalamic-pituitary-adrenal (HPA) axis. This is the hormonal cascade that governs cortisol production, and it is the central mechanism connecting psychological stress to physiological response.

The process works like this:

1. The hypothalamus perceives a stressor — physical, psychological, or social — and releases corticotropin-releasing hormone (CRH).
2. The pituitary gland responds to CRH by secreting adrenocorticotropic hormone (ACTH) into the bloodstream.
3. The adrenal glands receive the ACTH signal and produce and release cortisol.
4. Negative feedback loops — primarily through glucocorticoid receptors in the hippocampus and prefrontal cortex — signal the hypothalamus and pituitary to reduce CRH and ACTH when cortisol levels are adequate.

When this feedback system functions normally, cortisol rises quickly in response to stress and then returns to baseline. When the feedback system is disrupted, cortisol can remain chronically elevated, chronically suppressed, or follow an abnormal daily pattern.

HPA mental health research has demonstrated repeatedly that psychiatric conditions are associated with HPA axis dysfunction at multiple points in this cascade. The nature of that dysfunction varies considerably between conditions. Major depressive disorder is often associated with hyperactivity of the HPA axis — meaning the axis fires too readily, produces too much CRH, and generates cortisol responses that are slow to shut down. Post-traumatic stress disorder (PTSD), by contrast, has been more consistently associated with hypocortisolism — lower than normal cortisol levels, often alongside hypersensitivity of GRs, which paradoxically heightens biological responsiveness to stress.

HPA psychiatric research has also highlighted the importance of early life experience in calibrating the HPA axis. Adverse childhood experiences — abuse, neglect, household dysfunction — can permanently alter the set point of the HPA axis, making individuals more vulnerable to psychiatric disorders throughout their lives. This is a theme we return to in detail later in this post.

The complexity of the HPA psychiatric disorders landscape is part of what makes simple statements about "high cortisol equals mental illness" scientifically inaccurate. The relationship is nuanced, condition-specific, and mediated by dozens of genetic, developmental, and environmental factors.

---

Cortisol and Anxiety: What the Research Actually Shows

Of all the connections in cortisol anxiety depression research, the link between cortisol and anxiety has received some of the strongest recent support — though even here, the picture is not entirely straightforward.

The 2024 Mendelian Randomization Findings

A landmark study published in 2024 used Mendelian randomization methodology — a technique that uses genetic variants as natural experiments to estimate causal effects — to examine whether morning plasma cortisol was causally associated with anxiety, major depression, and neuroticism. The findings were striking in their specificity.

Morning plasma cortisol was positively associated with anxiety, with a pooled odds ratio of 1.16 per cortisol z-score (95% CI 1.04 to 1.31). This means that genetically predicted higher morning cortisol was associated with meaningfully elevated odds of anxiety disorders. By contrast, the same analysis found no significant association with major depression (OR 1.02, 95% CI 0.95 to 1.10) or neuroticism (β −0.025, 95% CI −0.071 to 0.022) [1].

This specificity matters enormously for cortisol psychiatric research. It suggests that morning cortisol may be more relevant to anxiety pathways than to mood disorder pathways generally, and that different psychiatric conditions may involve distinct cortisol mechanisms even though they frequently co-occur.

Why Does Cortisol Promote Anxiety?

The biological pathways connecting cortisol to anxiety are well-characterized. Elevated cortisol enhances amygdala reactivity — making the brain's threat-detection center more sensitive and more prone to triggering fear and alarm responses. At the same time, chronic cortisol elevation impairs prefrontal cortical function, reducing the brain's capacity to apply "top-down" regulation to emotional reactions. The result is a brain that is simultaneously more reactive to potential threats and less capable of rationally appraising and managing that reactivity.

Cortisol also interacts with the norepinephrine system, which governs arousal, and with GABA-ergic circuits that normally provide calming inhibition. Disruptions in these interactions can contribute to the hyperarousal, worry, and somatic symptoms characteristic of anxiety disorders.

Cortisol Across Specific Anxiety Conditions

Cortisol anxiety depression research has examined several specific anxiety presentations:

• Generalized Anxiety Disorder (GAD): Studies have found elevated basal cortisol and altered diurnal cortisol patterns in many patients with GAD, though effect sizes are moderate and findings vary across studies.
• Social Anxiety Disorder: Patients with social anxiety often show exaggerated cortisol responses to social evaluation tasks, suggesting HPA axis hyperreactivity to specifically social stressors.
• PTSD: As noted above, PTSD presents a paradoxical pattern — often characterized by lower basal cortisol but higher GR sensitivity, producing a system that is dysregulated rather than simply elevated or suppressed.
• Panic Disorder: Some studies have found blunted cortisol awakening responses in panic disorder, suggesting a different dysregulation profile than other anxiety conditions.

★★★★★ 4.8 · 1,247 reviews

Feel Calm By Bedtime. Focused By Morning.

Adaptogen-based formula. Third-party tested. Made in an FDA-registered facility. Backed by a 60-day money-back guarantee.

Shop Cortisol Drops →

✓ 60-day guarantee ✓ Free shipping $40+ ✓ Ships in 24hrs

Cortisol and Depression: A More Complex Picture

If the cortisol-anxiety relationship has clearer directional support, the relationship between cortisol and depression is genuinely more complicated — a nuance that recent cortisol psychiatric research has brought into sharper focus.

The Hypercortisolemia Model

The traditional model of cortisol and depression centers on hypercortisolemia: chronically elevated cortisol as both a biomarker and potential driver of depressive illness. This model is supported by the observation that approximately 40–60% of patients with major depression show evidence of HPA axis hyperactivity, including elevated cortisol, elevated CRH, enlarged pituitary glands, and failure to suppress cortisol in response to dexamethasone (the dexamethasone suppression test, or DST).

The 2026 cortisol mental health overview review on integrated cortisol management described chronic hypercortisolemia as contributing to a cluster of outcomes directly relevant to depression: memory deficits, anxiety, and depression [8]. When cortisol remains chronically elevated, hippocampal neurons are damaged — the hippocampus is particularly vulnerable to glucocorticoid toxicity. Hippocampal shrinkage is one of the most replicated neuroimaging findings in major depression, and excess cortisol exposure is one proposed mechanism.

The 2024 Morning Cortisol Study

A 2024 study of morning cortisol patterns reported elevated morning cortisol in participants with depressive symptoms, with the authors concluding that morning blood cortisol could serve as an early detector for depression [4]. This finding aligns with the model of HPA axis hyperactivity in depression and suggests potential clinical utility for morning cortisol sampling — though the authors were appropriately cautious about extrapolating from depressive symptoms to clinical diagnosis.

Why the Mendelian Randomization Found No Causal Link

The 2024 Mendelian randomization study's finding that morning cortisol was not causally associated with major depression (OR 1.02, 95% CI 0.95 to 1.10) might seem to contradict the hypercortisolemia model [1]. However, these findings can be reconciled.

Mendelian randomization examines genetically predicted cortisol levels — essentially, cortisol variation driven by inherited factors. This is different from examining cortisol changes that develop over the course of psychiatric illness, which may be shaped by the illness itself, by medication, by lifestyle changes, or by psychosocial stressors. It is entirely possible that:

1. Genetically driven morning cortisol differences do not substantially predict depression risk.
2. But cortisol dysregulation that emerges during depressive episodes is still real and clinically relevant.
3. The timing of cortisol sampling (morning vs. evening vs. diurnal slope) matters enormously for what the measurement captures.

This points to one of the fundamental challenges in cortisol mental illness research: cortisol is both a potential cause and a consequence of psychiatric symptoms, making causal inference difficult with observational methods.

Melancholic vs. Atypical Depression

It is also worth noting that within depression itself, cortisol patterns are not uniform. Melancholic depression — characterized by pervasive anhedonia, psychomotor retardation, and early morning wakening — is more consistently associated with HPA axis hyperactivity and elevated cortisol. Atypical depression — characterized by mood reactivity, hypersomnia, and increased appetite — is more often associated with HPA axis hypoactivity and support healthy cortisol. Treating these as the same biological entity when examining cortisol biomarkers is almost certainly incorrect.

Cortisol and Mood Disorders Beyond Depression

Cortisol mood disorders research extends well beyond unipolar depression. Bipolar disorder, dysthymia, and premenstrual dysphoric disorder (PMDD) have all been examined in the context of HPA axis function.

Bipolar Disorder

In bipolar disorder, cortisol patterns differ across mood states. During depressive episodes, HPA axis hyperactivity is common, mirroring findings in unipolar depression. During manic episodes, cortisol may be elevated but through different mechanisms, and the pattern of dysregulation differs from the depressive state. Some studies have found that HPA axis abnormalities persist even during euthymic (stable) periods in bipolar patients, suggesting that cortisol dysregulation may be a trait marker rather than a pure state marker in this condition.

The cortisol mood disorders literature has also examined the role of lithium — the gold-standard mood stabilizer for bipolar disorder — in modulating HPA axis function. Some evidence suggests that lithium may reduce HPA axis hyperactivity, which could contribute to its mood-stabilizing effects.

Premenstrual Dysphoric Disorder

PMDD offers a particularly interesting window into HPA mental health interactions. The condition involves severe mood symptoms tied to the luteal phase of the menstrual cycle. Research has found that women with PMDD show differential HPA axis responsivity across the cycle, with evidence of both heightened and blunted cortisol reactivity depending on the phase and the type of stressor. This suggests that ovarian hormones modulate HPA axis sensitivity in ways that interact with vulnerability to mood dysregulation.

Seasonal Affective Disorder

Seasonal affective disorder (SAD) — depression that follows a seasonal pattern, typically worsening in winter — has been examined in relation to cortisol. Some studies have found blunted cortisol awakening responses in SAD patients, with normalization during remission in spring and summer. This connects to the role of light exposure in regulating circadian rhythms, the HPA axis, and melatonin — a system explored further in the sleep section below.

Diurnal Cortisol Patterns: Morning vs. Evening Cortisol

One of the most important developments in recent stress mental health research is the growing appreciation that when cortisol is measured matters as much as the absolute level. Cortisol follows a pronounced daily rhythm: it peaks sharply in the first 30–45 minutes after waking (the cortisol awakening response, or CAR), declines through the morning, reaches its lowest point in the late evening, and begins rising again in the early hours of the morning before waking.

This diurnal rhythm is regulated jointly by the HPA axis and the circadian clock — specifically by the suprachiasmatic nucleus (SCN) of the hypothalamus, which receives light input from the retina and coordinates 24-hour biological rhythms throughout the body.

The 2026 Meta-Analysis: Evening Cortisol and Well-Being

A 2026 meta-analysis of four large cohort studies produced nuanced findings that challenge simpler framings of cortisol and well-being. The analysis found that morning cortisol, diurnal slope, and the cortisol awakening response were not associated with positive mental well-being. However, higher evening cortisol was prospectively associated with lower well-being in middle and older age [3].

This is a significant finding for several reasons. First, it shifts attention away from the morning cortisol that has dominated much of the measurement literature. Second, it suggests that the flattening of the diurnal slope — with relatively elevated cortisol persisting into the evening — may be more consequential for long-term mental health outcomes than peak morning cortisol levels. Third, the prospective design means that elevated evening cortisol preceded reductions in well-being, lending some directional support to a causal interpretation.

The Gut–Brain–Circadian Axis Connection

A 2025 review on the gut–brain–circadian axis in anxiety and depression drew direct connections between HPA-axis cortisol signaling and flattened diurnal cortisol rhythms, stress hypersensitivity, cognitive dysfunction, and sleep disturbance [6]. This research situates cortisol within a broader systems biology framework: the circadian clock, the gut microbiome, the immune system, and the HPA axis are not independent systems but are tightly coupled. Disruption in any one of them can propagate dysfunction across the others.

The practical implication is that a "flat" cortisol curve — where the normal steep morning-to-evening decline is replaced by a more level pattern with elevated evening values — may be both a marker and a driver of psychiatric vulnerability, operating through its downstream effects on sleep architecture, immune function, and cognitive performance.

Is Morning or Evening Cortisol More Important?

The question of whether morning or evening cortisol is more important for mental health does not have a single answer. Different aspects of mental health may be more closely tied to different portions of the diurnal curve:

• Anxiety has been more strongly linked to elevated morning cortisol in recent causal research [1].
• Well-being outcomes in aging populations appear more sensitive to elevated evening cortisol [3].
• Depression has been associated with both elevated morning cortisol and a flattened diurnal slope, depending on the subtype and severity.
• Cognitive function and sleep quality appear particularly sensitive to whether cortisol declines adequately in the evening.

For clinical and research purposes, this means that single-point cortisol measurements have limited utility. Assessing the full diurnal profile — at waking, 30 minutes post-waking, mid-afternoon, evening, and bedtime — provides a far richer picture of HPA axis function than any single measurement can offer.

★★★★★ 4.8 · 1,247 reviews

The Adaptogens Your Nervous System Has Been Missing.

Ashwagandha, rhodiola, and phosphatidylserine — clinically-studied ingredients that support healthy cortisol rhythms.

Shop Cortisol Drops →

✓ 60-day guarantee ✓ Free shipping $40+ ✓ Ships in 24hrs

Cortisol, Suicidal Behaviors, and Self-Injury

Among the more clinically urgent areas of cortisol psychiatric research is the question of whether cortisol dysregulation is associated with suicidal behaviors and non-suicidal self-injury (NSSI). Given the public health importance of these outcomes, understanding any biological markers that might help identify at-risk individuals is a research priority.

The 2025 Review: Mixed Evidence

A comprehensive 2025 review examining cortisol levels in suicidal behaviors and non-suicidal self-injury found that elevated cortisol was linked to suicidal behaviors, but the review also noted that findings were inconsistent across studies and no definitive cause-and-effect relationship was established [2].

The inconsistency in findings is not surprising given the methodological challenges in this research area:

• Heterogeneity in suicidal behavior measurement: Studies vary widely in whether they examine suicidal ideation, suicide attempts, completed suicide, or NSSI, which may have distinct biological profiles.
• Temporal confounds: Cortisol measured during a suicidal crisis is likely different from baseline cortisol between episodes. Many studies measure cortisol at different points relative to acute risk.
• Sample sizes: Many studies in this area have relatively small samples, reducing statistical power and increasing the risk of both false positives and false negatives.
• Comorbidity: Suicidal behaviors occur across a wide range of psychiatric diagnoses, each with its own cortisol profile, making it difficult to isolate a cortisol signature specific to suicidality.

What the Evidence Suggests

Despite these limitations, there is a plausible biological rationale for a cortisol-suicidality link. Chronic stress and HPA axis dysregulation can impair decision-making through effects on the prefrontal cortex, increase impulsivity through effects on dopaminergic circuits, disrupt sleep (a known risk factor for suicidal ideation), and amplify emotional pain through effects on the limbic system. The 2026 review on integrated cortisol management specifically identified chronic hypercortisolemia as contributing to depression [8] — itself a major risk factor for suicidal behavior.

At this stage, however, cortisol cannot be used clinically to predict suicidal risk. The evidence supports ongoing investigation rather than clinical application.

Childhood Adversity, Blunted Cortisol, and Long-Term Mental Health Risk

One of the most compelling findings in HPA mental health research concerns how early life experiences permanently recalibrate the stress response system — with consequences that unfold across decades of mental health.

The 2024 Review on Cortisol, Stress, and Childhood Adversity

A 2024 review published in a leading endocrinology journal examined bidirectional relationships between cortisol, stress, and disease, with particular attention to the role of childhood adversity. The review described blunted cortisol responses to social stress following childhood adversity as a risk marker for psychopathology, including mood disorders [5].

This finding might seem counterintuitive — if stress is harmful, shouldn't higher cortisol responses be more dangerous? The answer reflects the complexity of HPA psychiatric biology. Blunted cortisol responses to stress are not necessarily a sign of a healthier, more regulated system. In many cases, they reflect a system that has been chronically over-activated during development and has downregulated its reactivity as an adaptive response to persistent overwhelming stress. This "worn-out" or hyporesponsive system may fail to mount appropriate cortisol responses when they are actually needed, impairing the body's ability to manage new stressors effectively.

The Developmental Programming Model

The developmental programming model of HPA axis function proposes that experiences during sensitive periods of brain development — particularly prenatal life and early childhood — alter the long-term set point of the HPA axis by changing gene expression patterns (epigenetic mechanisms) and the density or sensitivity of GRs in the hippocampus and prefrontal cortex.

Specific forms of childhood adversity associated with HPA axis programming include:

• Childhood abuse (physical, sexual, emotional)
• Neglect and early emotional deprivation
• Prenatal stress (maternal stress during pregnancy)
• Early institutional care (orphanage rearing)
• Community violence and neighborhood-level adversity

These experiences do not just increase the risk of psychiatric illness in childhood — they alter stress physiology in ways that may contribute to elevated risk for depression, anxiety, PTSD, substance use disorders, and cardiovascular disease throughout the lifespan.

Implications for Stress Mental Health Research

This body of stress mental health research has profound implications for how we think about psychiatric vulnerability. It suggests that HPA axis dysregulation is not simply a symptom of current mental illness — it can be a lasting biological scar of adverse early experience that precedes and predicts later psychopathology. Identifying individuals with early-adversity-induced HPA axis dysregulation early in life — potentially through cortisol measurement — could theoretically enable targeted preventive interventions before psychiatric symptoms fully emerge.

Cortisol, Sleep, and Cognitive Function

The relationship between cortisol and mental health cannot be fully understood without examining its effects on two key intermediate mechanisms: sleep and cognitive function. Both serve as important bridges between HPA axis biology and psychiatric outcomes.

Cortisol and Sleep Architecture

Cortisol and sleep are locked in a circular regulatory relationship. The normal cortisol nadir in the late evening is essential for the initiation of sleep — particularly slow-wave sleep (SWS), which is the deepest and most restorative sleep stage. When evening cortisol is elevated (as in the pattern identified in the 2026 cohort meta-analysis [3]), SWS is suppressed, sleep initiation is delayed, and total sleep time is reduced.

In turn, poor sleep itself activates the HPA axis. Sleep deprivation raises cortisol, increases CRH, and sensitizes the system to further stress. This creates a bidirectional deterioration: elevated evening cortisol impairs sleep, and impaired sleep elevates cortisol, with cumulative mental health consequences over time.

The 2025 review on the gut–brain–circadian axis highlighted exactly this mechanism, linking HPA-axis cortisol signaling with sleep disturbance as one of the key downstream consequences of disrupted circadian-HPA coupling [6].

Cortisol and Cognitive Function

Cortisol's effects on cognitive function are dose-dependent and time-dependent. Moderate, acute cortisol elevation — as during normal morning waking or mild to moderate stress — enhances attention, working memory, and the encoding of emotionally significant information. This is adaptive: you pay closer attention and remember threatening experiences more clearly.

However, chronic or excessive cortisol exposure has the opposite effect. Memory deficits are among the most consistently documented consequences of chronic hypercortisolemia [8]. The hippocampus — critical for forming new declarative memories and for spatial navigation — is particularly vulnerable to glucocorticoid toxicity. Chronic cortisol exposure reduces hippocampal volume by suppressing neurogenesis, reducing dendritic branching, and ultimately causing neuronal loss.

Beyond the hippocampus, chronic cortisol exposure impairs prefrontal cortical function, reducing working memory capacity, attentional control, and cognitive flexibility. These are precisely the cognitive functions that support emotional regulation, problem-solving under stress, and effective coping — making cortisol-induced cognitive impairment a potential amplifier of psychiatric risk.

Measuring Cortisol: Saliva, Blood, Hair, and Urine Testing

A 2025 bibliometric analysis of salivary cortisol research described salivary cortisol as a key marker for assessing mental health status [7], reflecting the broader field's increasing interest in accessible, non-invasive cortisol measurement. Understanding the different methods of measuring cortisol is essential context for interpreting any study in this area.

Salivary Cortisol

Salivary cortisol measurement is currently the most widely used method in cortisol mental health research because it is:

• Non-invasive: Collection via passive drool or cotton swab causes no stress and can be done at home.
• Repeated measurement friendly: Multiple samples across a day can capture the diurnal curve.
• Biologically relevant: Salivary cortisol reflects free (unbound, biologically active) cortisol rather than total cortisol, which is arguably the more functionally relevant fraction.

Standardized protocols for salivary cortisol collection typically involve samples at waking, 30 minutes post-waking (to capture the cortisol awakening response), mid-morning, afternoon, evening, and bedtime, though protocols vary by research question.

Blood (Plasma or Serum) Cortisol

Blood cortisol is the standard clinical measurement and is used in most medical assessments of adrenal function. It measures total cortisol (both free and protein-bound). The 2024 Mendelian randomization study used morning plasma cortisol as its primary measure [1], and the 2024 morning cortisol patterns study used morning blood cortisol [4].

The limitation of blood cortisol is that venipuncture itself is a mild stressor that can acutely elevate cortisol, potentially confounding results. Collecting blood in a calm setting after an appropriate rest period, and typically in the morning, can minimize this confound.

Hair Cortisol

Hair cortisol measurement is an important advance in cortisol psychiatric research because it provides an index of cumulative cortisol exposure over weeks to months rather than a single time-point snapshot. Cortisol is incorporated into the hair shaft as it grows (approximately 1 cm per month), so a 3 cm segment of hair near the scalp reflects approximately three months of average cortisol secretion.

Hair cortisol is particularly valuable for research on chronic stress, childhood adversity, and long-term psychiatric risk, where the pattern of sustained cortisol exposure over time is more relevant than any single measurement.

Urinary Cortisol

24-hour urinary free cortisol measurement integrates total cortisol output across an entire day and remains a clinically important tool for diagnosing Cushing's syndrome. In psychiatric research, it has been used less frequently than salivary or blood measures but provides useful information about total daily cortisol production.

★★★★★ 4.8 · 1,247 reviews

See Why Athletes And Executives Take It Daily.

Adaptogen-based formula, third-party tested, made in the USA. Cancel subscription anytime.

Shop Cortisol Drops →

✓ 60-day guarantee ✓ Free shipping $40+ ✓ Ships in 24hrs

Can Cortisol Testing Diagnose Mental Illness?

This is one of the most common questions readers bring to cortisol and mental health overview resources, and the honest answer is: not yet, and possibly not in the simple way people imagine.

The Current State of the Evidence

Despite decades of research and considerable investment in identifying cortisol as a biomarker for psychiatric conditions, no cortisol test currently has sufficient sensitivity, specificity, or predictive value to diagnose any psychiatric disorder in clinical practice. The reasons are multiple:

1. Overlap with normality: Cortisol values in people with psychiatric disorders overlap substantially with values in healthy individuals. There is no cortisol level that reliably distinguishes, say, a person with major depression from a person without it.

1. Within-group heterogeneity: As discussed throughout this post, psychiatric diagnoses encompass heterogeneous populations with different biological subtypes, not all of which involve cortisol dysregulation.

1. Confounding factors: Cortisol is influenced by time of day, season, diet, sleep, exercise, medications, hormonal status, smoking, alcohol, BMI, and acute stress — all of which can vary between individuals being compared.

1. The specificity problem: Cortisol dysregulation is not specific to any one psychiatric condition. Elevated cortisol can be found in depression, anxiety, PTSD, early psychosis, substance use disorders, eating disorders, and many medical conditions. A positive result would not meaningfully narrow a differential diagnosis.

What Cortisol Testing Can Offer

While cortisol cannot diagnose psychiatric illness, it does have legitimate uses in mental health-related clinical assessment:

• Ruling out endocrine causes: In patients presenting with mood symptoms, anxiety, or cognitive changes, cortisol testing can help exclude Cushing's syndrome or adrenal insufficiency as primary causes.
• Research stratification: In research settings, cortisol measurement can help stratify patients into biologically more homogeneous subgroups that may respond differently to treatments.
• Monitoring treatment response: In some contexts, tracking cortisol across a treatment course may provide information about biological changes accompanying clinical improvement.
• Population-level risk research: As discussed, morning and evening cortisol patterns have value as population-level predictors of psychiatric risk, even if they are not diagnostic at the individual level.

The 2025 bibliometric analysis of salivary cortisol concluded that it is "a key marker for assessing mental health status" [7] — a carefully worded statement that acknowledges its value without overclaiming diagnostic utility. This captures the current scientific consensus well.

Chronic High Cortisol: Symptoms and Mental Health Consequences

Understanding what chronic high cortisol actually does to the brain and body is essential for appreciating its psychiatric relevance. The 2026 integrated management review described chronic hypercortisolemia as contributing specifically to memory deficits, anxiety, and depression [8] — but these are embedded within a broader constellation of effects.

Cognitive Symptoms

• Impaired memory formation: Particularly for neutral or positive information (stress memory bias)
• Working memory deficits: Reduced capacity to hold and manipulate information
• Difficulty concentrating: Disrupted attention and cognitive flexibility
• Mental fatigue: Heightened subjective effort required for cognitive tasks

Emotional and Behavioral Symptoms

• Heightened anxiety and worry: Through amygdala sensitization and prefrontal inhibition
• Emotional dysregulation: Reduced capacity to modulate emotional responses
• Irritability and mood lability: Particularly prominent in cortisol-related mood disruption
• Anhedonia: Reduced ability to experience pleasure, through effects on dopaminergic reward circuits
• Social withdrawal: Partly as a consequence of fatigue, mood disturbance, and cognitive impairment

Sleep Disruption

• Difficulty falling asleep: Elevated evening cortisol suppressing sleep initiation signals
• Reduced slow-wave sleep: With downstream effects on physical and cognitive restoration
• Early morning wakening: A cortisol-related phenomenon particularly common in melancholic depression

Physical Symptoms with Psychiatric Relevance

• Weight gain: Particularly central adiposity, which is itself associated with increased inflammatory signaling and poorer mental health
• Immune dysregulation: Chronic cortisol exposure initially suppresses and then can paradoxically sensitize inflammatory responses, with implications for the growing research on neuroinflammation in depression
• Gastrointestinal symptoms: Through cortisol's effects on gut motility and the gut microbiome, connecting to the gut-brain axis research discussed earlier [6]

HPA Psychiatric Disorders: What the Clinical Evidence Shows

Summarizing across the full landscape of HPA psychiatric disorders research, we can identify several well-characterized relationships and several areas where evidence remains incomplete or contested.

Well-Characterized Relationships

Cushing's Syndrome: The clearest demonstration that chronic hypercortisolemia causes psychiatric symptoms comes from Cushing's syndrome — a medical condition caused by pathologically excessive cortisol production (usually from an adrenal or pituitary tumor). Approximately 50–80% of patients with Cushing's syndrome develop significant depressive symptoms, with high rates of anxiety and cognitive impairment. Critically, these psychiatric symptoms typically improve after successful treatment of the cortisol excess, providing the strongest available evidence that excess cortisol can cause psychiatric symptoms rather than merely being associated with them.

PTSD: PTSD occupies a distinctive position in HPA psychiatric disorders research. The condition is often associated with hypocortisolism — lower than normal basal cortisol — alongside enhanced negative feedback (higher GR sensitivity), which keeps cortisol low despite ongoing stress. This paradoxical pattern has been interpreted as reflecting a system in which hyperresponsiveness and hypervigilance are maintained with minimal glucocorticoid fuel — a pattern that may serve some adaptive function in a continuing threat environment but that has serious long-term consequences.

Major Depression: As reviewed earlier, approximately 40–60% of patients with major depression show HPA axis hyperactivity, with elevated basal cortisol, elevated CRH, and DST non-suppression. This is particularly prominent in melancholic and psychotic subtypes of depression and in more severe illness.

Schizophrenia: Early psychosis and schizophrenia have been associated with elevated HPA axis activity, elevated cortisol, and increased stress sensitivity. There is ongoing research examining whether cortisol-mediated hippocampal damage may contribute to the cognitive deficits and volume reductions that characterize the disorder.

Areas of Active Investigation

• Borderline Personality Disorder (BPD): Characterized by emotional dysregulation and often a history of childhood adversity; HPA axis findings in BPD have been variable, with some studies finding elevated and others finding blunted cortisol reactivity.
• ADHD: Some studies have found blunted cortisol responses in children with ADHD, though findings are not consistent.
• Eating Disorders: Both anorexia nervosa (often associated with HPA hyperactivity driven partly by starvation) and bulimia nervosa have been examined in the context of cortisol dysregulation.
• Substance Use Disorders: Cortisol plays a role in craving, relapse, and stress-induced reinstatement of drug-seeking behavior, making it a target of active investigation in addiction psychiatry.

How Stress Changes Cortisol Over Time: Bidirectional Relationships

The 2024 review on "Cortisol, Stress, and Disease — Bidirectional Associations" [5] captures a central insight that underlies much of what this post has covered: the relationship between stress, cortisol, and mental health is not a simple one-way arrow. It is a dynamic feedback system in which each element shapes the others over time.

Acute Stress and Cortisol

In response to an acute stressor — a frightening event, a difficult confrontation, a physical threat — the HPA axis activates rapidly, producing cortisol within minutes. This acute response serves adaptive functions: it mobilizes energy, sharpens attention, consolidates emotionally salient memories, and modulates immune function. After the stressor passes, negative feedback mechanisms return cortisol to baseline.

Chronic Stress and HPA Dysregulation

When stress becomes chronic — sustained over weeks, months, or years — the HPA axis does not simply remain in a permanently activated state. Instead, it adapts, and the nature of that adaptation depends on the type, timing, and duration of the stressor.

In some individuals facing chronic stress, HPA hyperactivity persists, with chronically elevated cortisol and flattened diurnal rhythms. This pattern is associated with increased risk of depression, metabolic syndrome, immune dysregulation, and cognitive decline.

In others — particularly those with histories of early adversity or who have experienced overwhelming or inescapable stress — the HPA axis becomes blunted: less reactive to novel stressors, with lower basal cortisol and suppressed awakening responses. This pattern is more commonly associated with PTSD, some presentations of depression, and burnout.

Mental Illness Changes Cortisol

In the bidirectional relationship, the development of psychiatric illness itself further alters cortisol dynamics. Depression promotes HPA axis hyperactivity through altered limbic-hypothalamic connectivity. Anxiety disorders sensitize the stress response system, making cortisol responses to mild stressors larger and more prolonged. PTSD alters GR sensitivity, changing how the body responds to whatever cortisol is produced.

This means that cortisol patterns in people with psychiatric disorders reflect not just their baseline biology but the accumulated effects of their illness trajectory — which is why cross-sectional cortisol measurements in psychiatric patients are difficult to interpret and why longitudinal measurement designs are so valuable.

Can You "Support healthy cortisol" to Improve Mental Health?

This is a question that receives enormous attention in popular health culture, and the research is genuinely supportive of the idea that practices that reduce chronic stress can normalize cortisol patterns — though the relationship is not simply "support healthy cortisol = better mental health."

Interventions with documented effects on HPA axis function and mental health outcomes in the stress mental health research literature include:

• Mindfulness-based stress reduction (MBSR): Shown to support healthy cortisol awakening responses and improve anxiety and depression outcomes in multiple RCTs.
• Regular physical exercise: Has well-documented effects on normalizing diurnal cortisol patterns and improving mood.
• Cognitive-behavioral therapy (CBT): Some studies have found changes in cortisol patterns following successful CBT for anxiety and depression, consistent with the hypothesis that psychological treatment normalizes HPA function.
• Sleep improvement: Addressing sleep disorders can normalize evening cortisol elevation and break the sleep-cortisol deterioration cycle.
• Adequate social support: Consistent with the developmental programming model, secure and supportive relationships appear to buffer HPA axis reactivity.

★★★★★ 4.8 · 1,247 reviews

Ready To Try Adaptogen-Based Cortisol Support?

Third-party tested. 60-day guarantee. Free shipping over $40. Ships in 24 hours.

Shop Cortisol Drops →

✓ 60-day guarantee ✓ Free shipping $40+ ✓ Ships in 24hrs

Frequently Asked Questions

What does high cortisol do to mental health?

Chronically high cortisol is associated with anxiety, depression, memory problems, poor sleep, and emotional dysregulation. It sensitizes the amygdala (increasing fear and threat responses), impairs prefrontal cortical function (reducing rational emotional regulation), suppresses hippocampal neurogenesis (contributing to memory and mood problems), and disrupts sleep architecture. The 2026 integrated management review identified chronic hypercortisolemia as contributing to memory deficits, anxiety, and depression [8]. However, it is important to note that high cortisol is not always the cause of these symptoms — it is often both a contributor and a consequence of psychiatric distress.

Can cortisol cause anxiety or depression?

For anxiety, the evidence for a causal contribution is relatively strong. A 2024 Mendelian randomization study found that genetically predicted higher morning cortisol was associated with elevated anxiety risk (OR 1.16, 95% CI 1.04 to 1.31) [1]. For depression, the picture is more complex — the same study found no significant causal association between morning cortisol and major depression. Elevated cortisol does appear as a feature of many depressive presentations, particularly melancholic subtypes, but whether it is a cause or consequence of depression (or both) remains an active research question.

How do cortisol levels affect sleep and mood?

Elevated evening cortisol suppresses slow-wave sleep initiation and reduces total sleep time. A 2026 meta-analysis found that higher evening cortisol was prospectively associated with lower well-being in middle and older age [3]. The 2025 review on the gut-brain-circadian axis linked disrupted HPA-cortisol signaling with sleep disturbance, cognitive dysfunction, and stress hypersensitivity [6]. Poor sleep in turn elevates cortisol, creating a bidirectional deterioration that amplifies mood disturbance over time.

What is a normal cortisol level for mental health?

There is no single "normal" cortisol level that defines mental health. Cortisol values vary by time of day, measurement method, individual biology, age, sex, and circumstance. Reference ranges vary by laboratory and measurement method. More meaningful than any absolute value is the overall diurnal pattern — a healthy cortisol profile shows a clear peak in the first hour after waking, a progressive decline through the day, and a low nadir in the evening. Abnormalities in this pattern — particularly flattening of the slope or elevated evening values — are more associated with poor mental health outcomes than any single morning reading.

Is morning or evening cortisol more important?

The answer depends on which mental health outcome you are asking about. For anxiety, morning cortisol appears more relevant [1]. For longer-term well-being outcomes in middle and older age, elevated evening cortisol is a stronger predictor [3]. For depression, both an elevated morning cortisol and a flattened diurnal slope have been implicated, depending on the subtype and stage of illness. The most complete picture of HPA mental health status comes from measuring the full diurnal profile rather than relying on a single time point.

Can cortisol testing diagnose depression or anxiety?

No. Despite decades of research, no cortisol test has sufficient diagnostic accuracy to confirm or rule out a psychiatric diagnosis in clinical practice. Cortisol testing can exclude endocrine conditions (like Cushing's syndrome) that mimic psychiatric symptoms, and it has value as a research biomarker. The 2024 morning cortisol study suggested potential value as an early indicator of depressive symptoms [4], but this is quite different from a diagnostic test. Current psychiatric diagnoses remain based on clinical evaluation rather than biomarker results.

How can stress lower or raise cortisol over time?

Acute stress raises cortisol rapidly through HPA axis activation. With chronic, sustained stress, cortisol can remain chronically elevated — particularly when stress is unpredictable and uncontrollable. With certain types of overwhelming or inescapable stress, particularly in early life, the HPA axis may become blunted, producing support healthy cortisol responses to subsequent stressors. The 2024 review on childhood adversity described blunted cortisol as a risk marker for later psychopathology [5]. The direction of adaptation (hypercortisolism vs. hypocortisolism) appears to depend on stress characteristics, developmental timing, and individual genetic variation.

What are the symptoms of chronic high cortisol?

In the psychiatric domain, chronic high cortisol is associated with: persistent anxiety and worry, depressive symptoms, emotional dysregulation and irritability, poor sleep (particularly difficulty initiating sleep and reduced slow-wave sleep), memory and concentration problems, mental fatigue, and anhedonia. Physical symptoms that often accompany chronic high cortisol include: weight gain (especially abdominal), fatigue despite sleep, immune system dysregulation, gastrointestinal symptoms, and in severe cases (as in Cushing's syndrome), skin changes, muscle weakness, and hypertension.

Key Takeaways and Summary

This comprehensive cortisol and mental health overview research synthesis covers a rapidly evolving field with important recent developments. Here are the core evidence-based conclusions:

1. Cortisol and Anxiety Have the Strongest Causal Evidence

A 2024 Mendelian randomization study found that higher morning cortisol was causally associated with anxiety risk (OR 1.16), but not with major depression or neuroticism [1]. Cortisol's sensitization of the amygdala and impairment of prefrontal regulation provides biological plausibility for this link.

2. Cortisol and Depression Are Related But Causally Complex

Elevated morning cortisol in people with depressive symptoms suggests potential as an early indicator [4], but genetically driven cortisol variation does not appear to causally predict major depression [1]. The hypercortisolemia seen in depression may be more consequence than cause — though the two likely perpetuate each other.

3. Evening Cortisol Matters More for Long-Term Well-Being Than Previously Recognized

A 2026 meta-analysis found that evening cortisol — not morning cortisol or the cortisol awakening response — was prospectively associated with lower well-being in older age [3]. This shifts research attention toward the full diurnal profile.

4. HPA Axis Research Across Psychiatric Conditions Remains Heterogeneous

Different psychiatric disorders show different patterns of HPA dysregulation. Simple statements about "cortisol and mental illness" obscure important condition-specific differences between hyperactive HPA profiles (depression, anxiety) and hypoactive profiles (PTSD, burnout).

5. Childhood Adversity Permanently Recalibrates the HPA Axis

Blunted cortisol responses following childhood adversity predict later psychopathology [5], highlighting the developmental roots of many HPA-related psychiatric risks.

6. Cortisol Testing Cannot Diagnose Psychiatric Disorders

No cortisol measure currently has clinical diagnostic utility for psychiatric conditions, though testing can exclude endocrine causes and salivary cortisol remains valuable as a research and monitoring tool [7].

7. Suicidal Behavior and Cortisol: Evidence Is Promising But Inconsistent

Elevated cortisol was associated with suicidal behaviors in a 2025 review, but no causal conclusion was possible given heterogeneous findings and small sample sizes [2].

8. Chronic High Cortisol Has Multiple Mental Health Pathways

Chronic hypercortisolemia contributes to memory deficits, anxiety, and depression through hippocampal damage, amygdala sensitization, sleep disruption, and cognitive impairment [8].

9. The HPA Axis Is Part of a Larger Interconnected System

The 2025 gut–brain–circadian axis review [6] emphasizes that HPA cortisol dysregulation cannot be understood in isolation — it is deeply embedded in circadian, immune, and gut-brain systems that collectively determine psychiatric vulnerability.

10. The Field Is Advancing Rapidly

From Mendelian randomization designs enabling causal inference [1] to bibliometric mapping of cortisol research trends [7] to prospective cohort meta-analyses [3], the methodological sophistication of cortisol mental health research is growing. The coming decade is likely to yield increasingly actionable findings for clinical psychiatry.

This post is for informational and educational purposes only. Cortisol testing and its interpretation in clinical contexts should be conducted by qualified healthcare professionals. If you are experiencing mental health concerns, please consult a licensed mental health provider.

References

1. PMC 2024. Assessing the Role of Cortisol in Anxiety, Major Depression, and Neuroticism: Mendelian Randomization Study.
2. PMC 2025. Do Cortisol Levels Play a Role in Suicidal Behaviors and Non-Suicidal Self-Injury? A Review.
3. 2026 Cohort Meta-Analysis. Diurnal Cortisol Patterns and Mental Well-Being in Middle and Older Age.
4. JALHSS 2024. Morning Cortisol Patterns in Mental Health.
5. JCEM 2024. Cortisol, Stress, and Disease — Bidirectional Associations; Role for Childhood Adversity.
6. Frontiers 2025. The Gut–Brain–Circadian Axis in Anxiety and Depression.
7. Frontiers 2025. Research Prospect of Human Salivary Cortisol: A Bibliometric Analysis.
8. 2026. Integrated Management of Cortisol: A Multidimensional Review.